 Home > Active Ingredient News > Antitumor Therapy > European Radiology: Evaluation of response to yttrium-90 radioembolization in hepatocellular carcinoma using MRI

European Radiology: Evaluation of response to yttrium-90 radioembolization in hepatocellular carcinoma using MRI

 Last Update: 2022-10-10
 Source: Internet
 Author: User

Tags

photodynamic therapy cancer

liver cell types

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, accounting for 90% of all liver malignancies and the second leading cause of cancer-related death worldwide

However, 80% of patients were not eligible for curative treatment at the time of HCC diagnosis due to advanced tumor stage and/or background liver disease

Radiographic assessment of response after LRT is known to be challenging because lesions can exhibit heterogeneous necrosis and often do not initially decrease significantly in size

Recently, a study published in the journal European Radiology evaluated the diagnostic performance of gadoxetate disodium-enhanced MRI in predicting complete pathological necrosis (CPN) in HCC after TARE therapy using histopathology as a reference standard, for accurate clinical evaluation of treatment.

This retrospective study included 48 TARE-treated HCC patients (male/female: 36/12, mean age: 62 years), each of whom had a gadoxetate disodium MRI scan within 90 days of surgery

Histopathology revealed 71 HCCs (2.

This study demonstrates that subtraction (AP and PVP) and EASL criteria are independent predictors for evaluating CPN, with excellent diagnostic performance for CPN in TARE-treated HCC

Original source:

Naik Vietti Violi, Jeffrey Gnerre, Amy Law, et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.